Virpax Pharmaceuticals, Inc. (Virpax) has filed an SEC Form 3, indicating an initial statement of beneficial ownership of securities by Judy Su, a director and 10% owner of the company. The form, which was filed on July 15, 2024, following the event date of July 5, 2024, discloses that Judy Su does not beneficially own any securities directly or indirectly, including derivative securities such as puts, calls, warrants, options, or convertible securities. The filing was completed as required by Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940. The address provided for Judy Su is in Berwyn, PA. The form was signed by attorney-in-fact Vinay Shah on behalf of Judy Su.

Virpax Pharmaceuticals, Inc. (Virpax) has filed an SEC Form 3, indicating an initial statement of beneficial ownership of securities by Judy Su, a director and 10% owner of the company. The form, which was filed on July 15, 2024, following the event date of July 5, 2024, discloses that Judy Su does not beneficially own any securities directly or indirectly, including derivative securities such as puts, calls, warrants, options, or convertible securities. The filing was completed as required by Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940. The address provided for Judy Su is in Berwyn, PA. The form was signed by attorney-in-fact Vinay Shah on behalf of Judy Su.